Neurologix Overview

  • Founded
  • 1999
Founded
  • Status
  • Private
  • Employees
  • 12
Employees
  • Latest Deal Type
  • Liquidation
  • Financing Rounds
  • 9
  • Investments
  • 1

Neurologix General Information

Description

Neurologix Inc is a clinical-stage biotechnology company dedicated to the discovery, development, and commercialization of life-altering gene transfer therapies for serious disorders of the brain and Central Nervous System.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly PE-Backed
Primary Industry
Biotechnology
Primary Office
  • One Bridge Plaza
  • Fort Lee, NJ 07024
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Neurologix Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Neurologix‘s full profile, request access.

Request a free trial

Neurologix Executive Team (4)

Name Title Board Seat Contact Info
Matthew During MD Co-Founder
To view Neurologix’s complete executive team members history, request access »

Neurologix Board Members (4)

Name Representing Role Since
00000 0000000 Neurologix Board Member 000 0000
To view Neurologix’s complete board members history, request access »

Neurologix Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Neurologix Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000 0000000000 10-Feb-2004 000000000000000000 Holding Companies 0000000 0000000 00.0
To view Neurologix’s complete acquisitions history, request access »